ResourcesEnsuring Access and Approval for Innovative Therapies in Scleroderma
White Papers on Clinical Research
Understand our clinical research process and how we contribute to building innovative CRO solutions.
Ensuring Access and Approval for Innovative Therapies in Scleroderma
January 8, 2020
Clinical research and development programs for innovative therapies in scleroderma must accommodate the diverse data needs of multiple stakeholders. This white paper explores the requirements to create an integrated program capable of demonstrating the “value” of a new product, as well as clinical utility and therapeutic novelty.